290
A. S. Shinde et al.
58. Zheng Y, Yu B, Weecharangsan W, Piao L, Darby M, Mao Y, Koynova R, Yang X, Li H, Xu S,
Lee LJ (2010) Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery
of aromatase inhibitor 7α-APTADD to breast cancer cells. Int J Pharm 390:234–241
59. Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y (2010) Novel antitumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
J Control Release 141:22–29
60. Ando K, Mori K, Corradini N, Redini F, Heymann D (2011) Mifamurtide for the treatment
of nonmetastatic osteosarcoma. Expert Opin Pharmacother 12:285–292. https://doi.org/10.
1517/14656566.2011.543129
61. Karmali PP, Kotamraju VR, Kastantin M, Black M, Missirlis D, Tirrell M, Ruoslahti E (2009)
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomed Nanotechnol
Biol Med 5:73–82
62. Santra TS, Tseng F-G, Barik TK (2014) Biosynthesize silver and gold nanoparticles for
potential biomedical applications: a brief review. J Nanopharmaceutics Drug Deliv 2:1–17
63. Shinde AS, Mendhulkar VD (2020) Antiproliferative activity of Elephantopus scaber mediated silver nanoparticles against MCF-7, A-549, SCC-40 and COLO-205 human cancer cell
lines. Asian J Pharm Clin Res 13:163–67. https://doi.org/10.22159/ajpcr.2020.v13i2.36497
64. Santra TS, Tseng F-G, Barik TK (2015) Green biosynthesis of gold nanoparticles and
biomedical applications. Am J Nano Res Appl 2:5–12
65. Rabanel JM, Aoun V, Elkin I, Mokhtar M, Hildgen P (2012) Drug-loaded nanocarriers: passive
targeting and crossing of biological barriers. Curr Med Chem 19:3070–3102
66. Bonoiu AC, Mahajan SD, Ding H, Roy I, Yong KT, Kumar R, Hu R, Bergey EJ, Schwartz SA,
Prasad PN, Bonoiu AC, Mahajan SD, Ding H, Roy I, Yong KT, Kumar R, Hu R, Bergey EJ,
Schwartz SA, Prasad PN (2009) Nanotechnology approach for drug addiction therapy: gene
silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc Natl
Acad Sci 106:5546–5550
67. Daniels TR, Bernabeu E, Rodríguez JA, Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera G, Penichet ML (2012) The transferrin receptor and the targeted delivery of
therapeutic agents against cancer. Biochim Biophys Acta (BBA)-General Subj 1820:291–317
68. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin
receptor on endothelium of brain capillaries. Nature 312:162–163
69. Ulbrich K, Hekmatara T, Herbert E, Kreuter J (2009) Transferrin-and transferrin-receptorantibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB).
Biopharmaceutics 71:251–256
70. Gosk S, Vermehren C, Storm G, Moos T (2004) Targeting anti-transferrin receptor antibody
(OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ
perfusion. J Cereb Blood Flow Metab 24:1193–1204. https://doi.org/10.1097/01.WCB.000
0135592.28823.47
71. Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J (2013) Bromocriptine
loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic,
pharmacokinetic and scintigraphy study in mice. Eur J Pharm Sci 48:393–405
72. Davis PB, Cooper MJ (2007) Vectors for airway gene delivery. AAPS J 9:E11–E17
73. Buñuales M, Düzgüne N, Zalba S, Garrido MJ, Tros De Ilarduya C (2011) Efficient gene
delivery by EGF-lipoplexes in vitro and in vivo. Nanomedicine 6:89–98. https://doi.org/10.
2217/nnm.10.100
74. Felgner P, Tsai Y, Felgner J (1996) Advances in the design and application of cytofectin
formulations
75. Alex SM, Sharma CP (2013) Nanomedicine for gene therapy. Drug Deliv Transl Res 3:437–
445
76. Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman
JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ (2012) Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomed Nanotechnol Biol Med
8:1364–1371
A. S. Shinde et al.
58. Zheng Y, Yu B, Weecharangsan W, Piao L, Darby M, Mao Y, Koynova R, Yang X, Li H, Xu S,
Lee LJ (2010) Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery
of aromatase inhibitor 7α-APTADD to breast cancer cells. Int J Pharm 390:234–241
59. Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y (2010) Novel antitumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
J Control Release 141:22–29
60. Ando K, Mori K, Corradini N, Redini F, Heymann D (2011) Mifamurtide for the treatment
of nonmetastatic osteosarcoma. Expert Opin Pharmacother 12:285–292. https://doi.org/10.
1517/14656566.2011.543129
61. Karmali PP, Kotamraju VR, Kastantin M, Black M, Missirlis D, Tirrell M, Ruoslahti E (2009)
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomed Nanotechnol
Biol Med 5:73–82
62. Santra TS, Tseng F-G, Barik TK (2014) Biosynthesize silver and gold nanoparticles for
potential biomedical applications: a brief review. J Nanopharmaceutics Drug Deliv 2:1–17
63. Shinde AS, Mendhulkar VD (2020) Antiproliferative activity of Elephantopus scaber mediated silver nanoparticles against MCF-7, A-549, SCC-40 and COLO-205 human cancer cell
lines. Asian J Pharm Clin Res 13:163–67. https://doi.org/10.22159/ajpcr.2020.v13i2.36497
64. Santra TS, Tseng F-G, Barik TK (2015) Green biosynthesis of gold nanoparticles and
biomedical applications. Am J Nano Res Appl 2:5–12
65. Rabanel JM, Aoun V, Elkin I, Mokhtar M, Hildgen P (2012) Drug-loaded nanocarriers: passive
targeting and crossing of biological barriers. Curr Med Chem 19:3070–3102
66. Bonoiu AC, Mahajan SD, Ding H, Roy I, Yong KT, Kumar R, Hu R, Bergey EJ, Schwartz SA,
Prasad PN, Bonoiu AC, Mahajan SD, Ding H, Roy I, Yong KT, Kumar R, Hu R, Bergey EJ,
Schwartz SA, Prasad PN (2009) Nanotechnology approach for drug addiction therapy: gene
silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc Natl
Acad Sci 106:5546–5550
67. Daniels TR, Bernabeu E, Rodríguez JA, Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera G, Penichet ML (2012) The transferrin receptor and the targeted delivery of
therapeutic agents against cancer. Biochim Biophys Acta (BBA)-General Subj 1820:291–317
68. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin
receptor on endothelium of brain capillaries. Nature 312:162–163
69. Ulbrich K, Hekmatara T, Herbert E, Kreuter J (2009) Transferrin-and transferrin-receptorantibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB).
Biopharmaceutics 71:251–256
70. Gosk S, Vermehren C, Storm G, Moos T (2004) Targeting anti-transferrin receptor antibody
(OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ
perfusion. J Cereb Blood Flow Metab 24:1193–1204. https://doi.org/10.1097/01.WCB.000
0135592.28823.47
71. Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J (2013) Bromocriptine
loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic,
pharmacokinetic and scintigraphy study in mice. Eur J Pharm Sci 48:393–405
72. Davis PB, Cooper MJ (2007) Vectors for airway gene delivery. AAPS J 9:E11–E17
73. Buñuales M, Düzgüne N, Zalba S, Garrido MJ, Tros De Ilarduya C (2011) Efficient gene
delivery by EGF-lipoplexes in vitro and in vivo. Nanomedicine 6:89–98. https://doi.org/10.
2217/nnm.10.100
74. Felgner P, Tsai Y, Felgner J (1996) Advances in the design and application of cytofectin
formulations
75. Alex SM, Sharma CP (2013) Nanomedicine for gene therapy. Drug Deliv Transl Res 3:437–
445
76. Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman
JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ (2012) Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomed Nanotechnol Biol Med
8:1364–1371